A detailed history of Gw&K Investment Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 1,762,261 shares of HALO stock, worth $82.8 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
1,762,261
Previous 2,180,005 19.16%
Holding current value
$82.8 Million
Previous $114 Million 11.63%
% of portfolio
0.86%
Previous 1.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$51.3 - $64.42 $21.4 Million - $26.9 Million
-417,744 Reduced 19.16%
1,762,261 $101 Million
Q2 2024

Aug 12, 2024

SELL
$37.81 - $52.4 $637,930 - $884,092
-16,872 Reduced 0.77%
2,180,005 $114 Million
Q1 2024

May 08, 2024

SELL
$33.68 - $41.95 $998,982 - $1.24 Million
-29,661 Reduced 1.33%
2,196,877 $89.4 Million
Q4 2023

Feb 09, 2024

SELL
$33.32 - $42.1 $3.92 Million - $4.96 Million
-117,767 Reduced 5.02%
2,226,538 $82.3 Million
Q3 2023

Nov 09, 2023

SELL
$36.46 - $44.03 $1.29 Million - $1.55 Million
-35,284 Reduced 1.48%
2,344,305 $89.6 Million
Q2 2023

Aug 09, 2023

SELL
$30.28 - $38.74 $682,087 - $872,657
-22,526 Reduced 0.94%
2,379,589 $85.8 Million
Q1 2023

May 09, 2023

BUY
$32.86 - $55.7 $10.3 Million - $17.4 Million
313,259 Added 15.0%
2,402,115 $91.7 Million
Q4 2022

Feb 10, 2023

SELL
$40.06 - $59.44 $4.57 Million - $6.79 Million
-114,186 Reduced 5.18%
2,088,856 $119 Million
Q3 2022

Nov 09, 2022

BUY
$38.53 - $51.78 $21.6 Million - $29 Million
559,654 Added 34.05%
2,203,042 $87.1 Million
Q2 2022

Aug 09, 2022

SELL
$37.35 - $48.3 $391,091 - $505,749
-10,471 Reduced 0.63%
1,643,388 $72.3 Million
Q1 2022

May 09, 2022

BUY
$31.97 - $41.06 $3.04 Million - $3.91 Million
95,215 Added 6.11%
1,653,859 $66 Million
Q4 2021

Feb 11, 2022

BUY
$31.82 - $40.75 $1.91 Million - $2.44 Million
59,875 Added 3.99%
1,558,644 $62.7 Million
Q3 2021

Nov 10, 2021

BUY
$38.47 - $46.42 $16.8 Million - $20.2 Million
435,575 Added 40.97%
1,498,769 $61 Million
Q2 2021

Aug 10, 2021

BUY
$38.84 - $51.31 $76,281 - $100,772
1,964 Added 0.19%
1,063,194 $48.3 Million
Q1 2021

May 11, 2021

BUY
$39.51 - $51.45 $8.65 Million - $11.3 Million
218,975 Added 26.0%
1,061,230 $44.2 Million
Q4 2020

Feb 05, 2021

BUY
$25.81 - $43.62 $21.7 Million - $36.7 Million
842,255 New
842,255 $36 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.54B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.